Researchers in Germany have issued an alert after discovering a “striking” safety signal among children who received Covid mRNA “vaccines.”
They found that alarming numbers of vaccinated children have been impacted with disturbing psychological, pulmonary, gastrointestinal, neurological, and dermatological side effects.
Specifically, the researchers warn that children aged between 5 and 11 who received the Pfizer-BioNTech BNT162b2 Covid mRNA “vaccine” face significant risk.
The findings were revealed during a study led by Sarah Holzwarth at the Department of Pediatrics, Faculty of Medicine, University Hospital Carl Gustav Carus, Technische Universität Dresden in Germany.
The study’s paper was published in the Springer Nature Infection journal.
The researchers conducted the study to track the safety of the Pfizer mRNA injection in children with and without comorbidities aged 5 to 11 years.
This prospective, multicenter, industry-independent cohort study involves caregivers who are vaccinated.
The caregivers participated in a robust, well-designed online questionnaire.
Potential side effects were evaluated in ten organ-related categories.
The authors compared the frequency of symptoms in both cohorts by bivariate analysis.
They found a striking pattern of vaccine-induced risk associated with children with comorbidities.
The German-based study findings are deeply troubling given the magnitude of children with comorbidities.
In the United States, for example, about 40% of school-aged children have at least one comorbidity condition, a large population.
In 2023, there were 28,326,010 children aged 5 to 11 in the U.S.
According to the study, 40% of that population – 11.33 million American children – face “striking” health risks from the mRNA “vaccines.”
The parents and guardians of these children were relentlessly warned about the alleged risks of COVID-19 infection and pressured to vaccinate kids.
However, vaccination carries significant dangers that far outweigh any alleged risks from the virus.
The German study involved a broad investigation approach and random sampling of children with comorbidities treated at four different university children’s hospitals in Germany.
Their findings were compared to simultaneously enrolled age-matched healthy controls.
Out of 1,294 responses to the questionnaire, the team included 793 datasets from the analysis.
The data sets included 179 children with comorbidities and 614 healthy children.
With a median response time of 17 days post-vaccination, the overall safety of the Pfizer-BioNTech vaccine was considered in both cohorts.
They found that psychological, pulmonary, gastrointestinal, neurological, and dermatological side effects increased in children with comorbidities over healthy controls.
Based on these substantially higher Odds Ratios, the authors declare:
“The higher rate of reported post-vaccination symptoms could either be due to a higher susceptibility for symptomatic effects following immune stimulation or due to a trained awareness of health-related symptoms.
“The data emphasizes the importance of evaluating the safety of the new mRNA COVID-19 vaccines not only in healthy children but also in children with comorbidities.
“To perform such evaluation should be made mandatory for pharmaceutical enterprises.”
The authors found that “children with comorbidities report more side effects after vaccination with BNT162b2 than healthy children.”
The researchers note that no clinical trials were conducted for children with comorbidities before the “vaccines” were approved for use on kids.
Yet the government promoted the vaccine to this cohort even more intensely, with less disclosure.
These side effects include gastrointestinal, otolaryngologic, pulmonary, neurological, psychological, and dermatological symptoms.
As an example, children with comorbidities faced a 4.3 times higher risk for nausea and vomiting after receiving an mRNA vaccination than healthy children.
Children with comorbidities experienced higher fevers more frequently.
The researchers found that the vaccine-induced spike protein was the most likely culprit.
Behind several side effects the authors point to “a disturbance in the ACE-2/RAAS system by the spike protein produced after vaccination with BNT162b2, including as a result endothelial dysfunction.”
Other proposed causes include pro-inflammatory cytokines impacts.
The researchers refer to the safety profile difference in healthy children and children with comorbidities as “striking.”
However, they are not sure what the cause for this striking difference is in safety profiles.
The German study is just the latest to discover alarming health risks for children who received Covid “vaccines.”
As Slay News reported, another team of leading emergency pediatric medicine researchers sounded the alarm last week over surging cases of heart damage in children who received Covid mRNA “vaccines.”
During a major study, the eminent Irish researchers analyzed the cases of dozens of children who had been hospitalized with heart-related problems.
Alarmingly, every single one of the children had been given at least one dose of a Covid mRNA vaccine before they were admitted to hospital.
The researchers were unable to find any such reports of heart damage among unvaccinated children.
The study was conducted over an 11-month period at the Department of Pediatric Emergency Medicine at Tallaght Hospital in Dublin, Ireland.
In addition, another major study, this time involving 1.7 million children, found that heart damage only appeared in children who had received Covid mRNA vaccines.
Not a single unvaccinated child in the group suffered from heart-related problems, as Slay News recently reported.
The researchers also note zero children from the entire group, vaccinated or unvaccinated, died from COVID-19.
Furthermore, the study found that Covid shots offered the children very little protection from the virus, with many becoming infected after just 14 to 15 weeks of receiving an injection.
The 1.7 million children observed in the study were between the ages of 5 to 15 and were registered with the UK’s National Healthcare System (NHS).
The study was conducted by a team of leading UK medical doctors, epidemiologists, biostatisticians, and public health experts led by Oxford University’s Professor Colm D Andrews.
No comments:
Post a Comment